• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 9, 2000

View Archived Issues

Ribozyme repurchases rights to Heptazyme; phase II trial to begin

Read More

Cellegy's Rx for sexual dysfunction in women completes phase I/II

Read More

Canadian approval sought by Avanir for docosanol cream

Read More

Myogen to use SBIR grant for cardiac hypertrophy drug discovery

Read More

Two dendritic/cancer cell fusion trials begun by Genzyme Molecular Oncology

Read More

Atrix/Elan joint venture for cancer pain therapy selects fentanyl as first development compound

Read More

AMG-073 normalizes total serum calcium in hyperparathyroidism

Read More

LY-510929: Ligand's new drug candidate for diabetes and obesity

Read More

Vardenafil's preclinical profile supports potential in ED; other PDE5 inhibitors in the pipeline

Read More

Prophylactic efficacy of FK-463 against P. carinii infection demonstrated in mice

Read More

ABT-773 shows promise as antimicrobial agent in bite wound infections

Read More

Natural compound improves hypertension

Read More

Novel marine antifungal products sought in MycoLogics collaboration

Read More

Wyeth-Ayerst presents new SERM with potentially improved therapeutic profile

Read More

Analgesic activity of S-19812 assessed in rodent models and reported at OARSI meeting

Read More

Potent and selective EP2 receptor agonist with bone anabolic effects presented at ASBMR

Read More

Central 5-HT2C receptor agonist exerts proerectile activity in two animal species

Read More

Neuroprotective adenosine receptor ligands emerge from Novo Nordisk SAR studies

Read More

New triazole antifungal in development for use in deep mycoses

Read More

Favorable in vitro profile reported at ICAAC for BCH-13520, a new anti-HIV candidate

Read More

Small-molecule inhibitor of MT1-MMP discovered at Parke-Davis

Read More

Novel series from Isis Innovation possesses antiprotozoal, antitumor and other activities

Read More

Lilly's new 5-ht1F receptor agonists and their use in migraine

Read More

Two series synthesized at Boehringer Ingelheim exert sodium channel blockade

Read More

Steroid vitronectin receptor ligands discovered during joint research program

Read More

AstraZeneca presents new tyrosine kinase inhibitors with immunomodulating activity

Read More

Benzenesulfonamide B2 antagonists synthesized at Fournier

Read More

NitroMed's newest NO- and/or NO2-containing proton pump inhibitors

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 7, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 7, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Deal handshake with coin, chart background

    After axing 95% workforce, Vor bets $4B+ on Remegen’s telitacicept

    BioWorld
    Just a month after laying off 147 employees and announcing plans to mull “strategic alternatives,” Vor Biopharma Inc. reported raising $175 million in private...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe